WHO Sounds Alert Over Severe Scarcity of Obesity Jabs
Fewer than a tenth of people that would benefit from weight-loss injections like Wegovy are able to get them, warns the WHO as it issues its first advice on the therapies.
With in excess of 1,000,000,000 people worldwide currently living with obesity, it is advocating for broader and more equitable access to GLP-1 medication.
Based on forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 unless action is taken.
"Our latest guidelines acknowledges that excess weight is a lifelong illness that can be managed with holistic and continuous care," stated WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and distribution challenges are major barriers to universal access to the treatments that can assist patients in reducing substantial body mass, explains the agency.
Skinny Jab Scarcity
Even under the present best projected outlook, the production of GLP-1 therapies might only reach about 100 million people – under 10% of eligible patients, as stated by the WHO.
The guideline encourages countries and companies to increase access, through measures like voluntary licensing.
The intellectual property rights on the active ingredient – the primary ingredient of the drug Wegovy – is due to expire in a number of nations in 2026.
How Obesity Injections Function
These medications mimick a body's own hormone to reduce digestion speed, curb appetite and increase the sense of being full so people reduce food intake.
Patients commonly start to lose weight in the initial weeks of starting on the once-weekly jabs.
Evidence points to patients may put most of the weight back on within a year of discontinuing the drug, as their usual hunger return.
Being carrying excess weight increases your chance for experiencing diseases, such as type 2 diabetes, cardiovascular issues, stroke, and certain cancers.
Excess weight impacts people in every country and was linked to over three and a half million deaths worldwide in 2024, according to the health agency.
